Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Published 20/09/2023, 19:10
© Reuters.  Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Digital Transformation Opportunities Corp. (NASDAQ: DTOC) rose 100.7% to $27.50 after dipping 53% on Tuesday.

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) gained 56.4% to $4.8499. Bluejay Diagnostics, last month, announced a $1.59 million registered direct offering of 216,000 shares at $7.365 per share.

Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) shares gained 50% to $0.8705 after the company announced its Board of Directors has approved a plan of liquidation and dissolution.

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 38% to $0.1478.

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares gained 32.9% to $0.6974 after falling 10% on Tuesday.

Evaxion Biotech A/S (NASDAQ: EVAX) gained 29.2% to $0.6201. Evaxion partnered with pharmaceutical company Afrigen Biologics to develop novel mRNA vaccine against gonorrhoea.

Steelcase Inc. (NYSE: SCS) jumped 27.3% to $11.22. Steelcase reported better-than-expected results for its second quarter.

Solowin Holdings (NASDAQ: SWIN) gained 26% to $3.08.

Cambridge Bancorp (NASDAQ: CATC) rose 23.9% to $60.22 after the company announced it entered into a definitive agreement to merge with Eastern Bankshares.

Histogen Inc. (NASDAQ: HSTO) shares rose 23.4% to $0.4873. Histogen shares fell 40% on Tuesday after the company announced its Board of Directors approved a Plan of Dissolution.

Genius Group Limited (NYSE: GNS) jumped 22.2% to $1.0750. Genius Group signed a joint venture partnership with Groove Digital Inc and Groove AI to deliver artificial-intelligence powered tools to GeniusU partners and faculty.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) gained 22% to $0.3047.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

eHealth, Inc. (NASDAQ: EHTH) gained 20.1% to $8.07. eHealth Form 4 filing showed Director Dale B Wolf bought 15,000 shares at an average price of $7.05.

Asset Entities Inc. (NASDAQ: ASST) jumped 19.4% to $0.64.

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) rose 17.7% to $1.8606. Atara Biotherapeutics announced plans to submit Tab-cel BLA in the second quarter of 2024 following FDA agreement on comparability.

EBET, Inc. (NASDAQ: EBET) shares gained 16.7% to $0.0618.

Azul S.A. (NYSE: AZUL) jumped 12.8% to $9.33. Goldman Sachs upgraded Azul from Neutral to Buy and raised the price target from $14.9 to $18.3.

The Hain Celestial Group, Inc. (NASDAQ: HAIN) jumped 9% to $10.60.

Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) gained 8.3% to $2.9350 as the company disclosed preliminary traffic figures for August.

Losers

Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares fell 75.2% to $0.2477 after the company announced its SLS-002 Phase II study did not meet the pre-defined primary endpoint due to limited sample size.

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) fell 55.1% to $2.9650. The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals’ New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for adults and children ≥30 kg.

Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares fell 40% to $0.1181 after jumping 160% on Tuesday.

Molekule Group, Inc. (NASDAQ: MKUL) fell 37.6% to $0.4589. Molekule Group said board authorized the company’s management to commence preparation of voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

IceCure Medical Ltd (NASDAQ: ICCM) fell 36.6% to $0.57 after the company announced the FDA has at this time denied its De Novo Classification request for breast cancer which was submitted based on interim analysis from its ICE3 study.

QuantaSing Group Limited (NASDAQ: QSG) declined 36.4% to $3.47.

Bird Global, Inc. (NYSE: BRDS) shares fell 32.2% to $0.97. Bird Global shares jumped more than 103% on Tuesday after the company announced its purchase of micromobility operator Skinny Labs for $19 million.

Gorilla Technology Group Inc. (NASDAQ: GRRR) declined 24.6% to $1.07. Gorilla announced a $25 million registered direct offering of convertible preferred stock.

Cheche Group Inc. (NASDAQ: CCG) shares fell 22.8% to $25.00 after falling 56% on Tuesday.

Elutia Inc. (NASDAQ: ELUT) fell 18.8% to $1.34 after jumping 33% on Tuesday. The company announced a $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.

Cazoo Group Ltd (NYSE: CZOO) declined 16.9% to $0.8227. Cazoo announced deleveraging plan with noteholders and shareholders, enhancing financial flexibility.

Axcella Health Inc. (NASDAQ: AXLA) declined 16.6% to $10.13. The company recently announced 1-for-25 reverse stock split.

TD Holdings, Inc. (NASDAQ: GLG) fell 12.6% to $0.1510 after gaining 7% on Tuesday.

CSP Inc. (NASDAQ: CSPI) fell 12.6% to $17.13.

Calidi Biotherapeutics, Inc. (NASDAQ: CLDI) fell 10.1% to $3.04.

ImmunityBio, Inc. (NASDAQ: IBRX) tumbled 9.2% to $1.6250.

Neumora Therapeutics, Inc. (NASDAQ: NMRA) shares fell 8% to $11.02.

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) fell 7.4% to $9.97.

BeiGene, Ltd. (NASDAQ: BGNE) fell 7.2% to $193.86. B of A Securities analyst David Li maintained BeiGene with a Neutral and lowered the price target from $224.13 to $212.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Color Star Technology Co., Ltd. (NASDAQ: ADD) declined 7% to $1.4599.

Now Read This: Top 4 Financial Stocks That May Fall Off A Cliff

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.